Progyny Inc
USUSDProgyny Inc (US:PGNY) — Misc Health and Biotechnology Services. Number of exchanges where the company shares trade: 1. On this page — price and chart, dividends, top holders and share count history.
About the company
- Website
- progyny.com
- Investor relations
- investors.progyny.com/
- Sector
- Health Care · Misc Health and Biotechnology Services
- Headquarters
- NEW YORK, United States
- Management
- Peter Anevski
- Employees
- 835
- IPO
- 2019-10-25
- Shares outstanding
- Free float
- 67.41 M
- Market cap
- 2.57 B USD
- Insiders
- 2.04%
- Institutions
- 112.06%
- Industry (SIC)
- Services-Misc Health & Allied Services, NEC
- P/EP/E (Price / Earnings) — how many years of the company's profit you pay for a share. Calculated: current price ÷ net earnings per share over the last 12 months. Lower means cheaper relative to profit. Not calculated when the company has a loss (—).
- 32.5
- EPSEPS (Earnings Per Share) — the company's net profit over the last 12 months divided by the number of its shares, in the currency of this listing. A negative value (red) means a loss. P/E is the share price divided by EPS.
- 1.09 USD
- |P/B (price to book) — share price ÷ shareholders' equity per share from the latest balance sheet. Graham — as Benjamin Graham counted it: equity without goodwill, other intangible assets and preferred stock, that is tangible book value. He considered up to 1.5 acceptable for a defensive investor (green), or a product P/E × P/B up to 22.5. With negative tangible equity, Graham's P/B is not calculated.
- 6.406.82
- Graham numberGraham number — the highest price Benjamin Graham considered reasonable for a defensive investor: √(22.5 × EPS × tangible book value per share), where 22.5 = P/E 15 × P/B 1.5. A price below it (green) passes both of his limits at once. Not calculated with a loss or negative tangible equity.
- 11.29 USD price 214% above
- ROEROE (return on equity) is net income over the last 12 months divided by average shareholders' equity over those 12 months. It shows how much profit the company earns on every 100 dollars of capital. Consistently above 15% is a sign of a strong business, but a high ROE can also come from heavy debt or small equity after buybacks. One-off gains (sale of a business, revaluation, tax benefit) are excluded; «!» explains why the value differs from the reported one or is unreliable. Companies with negative equity have no ROE.
- 19.1%
- FCFFCF (Free Cash Flow) — money left to the company after operating costs and investment in equipment; dividends are safest when paid from it. Calculated: operating cash flow − capital expenditure, over the last 12 months, in the reporting currency.
- 180 M USD
- DebtDebt — all loans and bonds of the company per the latest report (short- and long-term), in the reporting currency. Below — how many years the company would need to repay net debt (debt minus cash) from its free cash flow: net debt ÷ FCF. Up to 3 years — good, 3–6 — moderate, over 6 — high. «Net cash» — net debt is negative.
- ?
- Earnings and FCF — for the 12 months to 30.09.2026 (the company's latest report).
- Net income
- NAVNAV — net asset value by the balance sheet: the company's assets minus its liabilities, the share of the company's shareholders (without other owners' stakes in its subsidiaries). Shown per share, with P/NAV — how many times the share price exceeds NAV per share (below 1 — the share costs less than its net assets on the balance sheet). Click to see what NAV is made of and its history.
Description
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Exchanges and tickers
| Exchange | Ticker | Currency | Price | Type |
|---|---|---|---|---|
| US USA Stocks | PGNY | USD | 35.45 -1.96% | common stock |
Candles
Each candle is one trading day. The thick part runs from the open price to the close price: green — the day closed higher than it opened, red — lower. The thin line runs from the lowest to the highest price of the day. Hover or tap a day to see all four prices.
P/E
The share price divided by the company earnings per share for the last 12 months (EPS). It shows how many years the company would need to earn its current profit to «pay back» the price: a lower P/E means the stock is cheaper relative to earnings. The line has its own scale on the left.
For some companies earnings come from their quarterly reports: on the day of a new report P/E jumps (a purple tick at the bottom of the chart), between reports it changes only with the price. For others P/E uses current earnings, so before the latest report it is approximate. If earnings are negative, P/E is not shown.
My position
Visible only to you and only if this stock is among your open portfolio positions (purchases in the same currency as the chart exchange). From each purchase date there is a dashed line at the purchase price, and between it and each day close price — an area: green if the position is in profit, red if at a loss. If you sold part, the remainder is shown: a sale writes off the earliest purchases first. The day tooltip shows how many shares were in the position and the gain or loss in money and %.
News this week
Press releases from the company's investor website, updated daily. Links lead to the company's website. Headlines are in the original language, as on the company website.
Top holders
| Holder | Stake | Shares | Report date |
|---|---|---|---|
| Blackrock Inc. | 15.12% | 11.6 M | 2026-06-30 |
| FMR, LLC | 9.13% | 7 M | 2026-06-30 |
| Vanguard Portfolio Manag… | 6.54% | 5.02 M | 2026-06-30 |
| iShares Trust-iShares Co… | 5.95% | 4.57 M | 2026-09-30 |
| Vanguard Capital Managem… | 4.18% | 3.21 M | 2026-06-30 |
| State Street Corporation | 3.94% | 3.02 M | 2026-06-30 |
| Ameriprise Financial, In… | 3.6% | 2.76 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.92% | 2.24 M | 2026-06-30 |
| Fidelity Securities Fund… | 2.64% | 2.03 M | 2026-08-31 |
| Geode Capital Management… | 2.57% | 1.97 M | 2026-06-30 |
| Touchstone Strategic TRT… | 2.53% | 1.94 M | 2026-06-30 |
| American Century ETF Tru… | 2.51% | 1.93 M | 2026-09-30 |
| iShares Trust-iShares Ru… | 2.48% | 1.9 M | 2026-09-30 |
| Citadel Advisors Llc | 2.33% | 1.79 M | 2026-06-30 |
| Dimensional Fund Advisor… | 2.31% | 1.77 M | 2026-09-30 |
| Fort Washington Investme… | 2.13% | 1.64 M | 2026-09-30 |
| VANGUARD INDEX FUNDS-Van… | 2.11% | 1.62 M | 2026-06-30 |
| Fidelity Rutland Square… | 1.62% | 1.25 M | 2026-09-30 |
| Fidelity Securities Fund… | 1.35% | 1.03 M | 2026-08-31 |
| VANGUARD INDEX FUNDS-Van… | 1.21% | 927 416 | 2026-06-30 |
| ANEVSKI PETER (Chief Exe… | ≈1.06% | 816 834 | 2026-03-02 |
| PAYSON NORMAN (Director) | ≈0.61% | 466 205 | 2026-05-21 |
| SCHLANGER DAVID J (Offic… | ≈0.31% | 240 633 | 2025-11-10 |
| SWARTZ ALLISON (General… | ≈0.11% | 83 976 | 2026-11-02 |
| LIVINGSTON MARK S (Chief… | ≈0.1% | 74 688 | 2026-06-04 |
| CUMMINGS MELISSA B (Chie… | ≈0.09% | 69 934 | 2026-07-14 |
| CLAPP GEOFFREY (Officer) | ≈0.08% | 60 647 | 2026-06-02 |
| PARK JEFFREY G (Director… | ≈0.05% | 39 981 | 2026-05-21 |
| HOLSTEIN ROGER C (Direct… | ≈0.04% | 28 729 | 2026-05-21 |
| DEAN LLOYD H (Director) | ≈0.03% | 26 519 | 2026-05-21 |
